Debio 0123 in Combination With Carboplatin and Etoposide in Adult Participants With Small Cell Lung Cancer That Recurred or Progressed After Previous Standard Platinum-Based Therapy
Clinical trial NCT05815160 · TERMINATED
Trial details
- NCT number
- NCT05815160
- Sponsor
- Debiopharm International SA
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-02
- Primary completion
- 2026-03-09
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.